![]() Financial Daily from THE HINDU group of publications Tuesday, Jan 22, 2002 |
|
|
|
|
|
Home Page
-
New Products & Services Corporate - New Products & Services Cadila to launch Fosinopril Our Bureau
NEW DELHI, Jan. 21 CADILA Pharmaceuticals Ltd (CPL) is preparing for a nation-wide launch of Fosinopril, its ACE inhibitor with compensatory dual route. Fovas, the cardio-vascular drug, launched in Ahmedabad this month, will be rolled out in the rest of the country subsequently. Fosinopril has a dual route of elimination and is cleared both through the liver and kidney.
Send this article to Friends by E-Mail
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |
Copyright © 2002, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|